Journal of Addiction Medicine

Scientists Find Kratom Alkaloids in Products Marketed as Kava in Alabama

In a study published June 30 in Clinical Toxicology, scientists found mitragynine, 7-hydroxymitragynine, and mitragynine-pseudoindoxyl in three liquid shot products being sold as “kava” in Alabama. Alabama law specifically lists mitragynine and 7-hydroxymitragynine as Schedule I controlled substances. Though mitragynine-pseudoindoxyl is not specifically listed as a controlled substance in the state, it is controlled as …

Scientists Find Kratom Alkaloids in Products Marketed as Kava in Alabama Read More »

Kratom Use Disorder Treatment with Methadone an Ongoing Practice

A case series published recently in the Journal of Addiction examined 14 American patients of Community Medical Services, a healthcare company specializing in the medically assisted treatment of Opioid Use Disorder (OUD). The patients were diagnosed with Kratom Use Disorder (KUD) (Sherrick, 2026). The very brief report does not get into specifics about kratom product …

Kratom Use Disorder Treatment with Methadone an Ongoing Practice Read More »